Showing results (761-770 of 1,725) with videos related to
Sort By:
Pageof 173
Drugs of Today (Barcelona, Spain : 1998)|June 3, 2016
Venetoclax: Bcl-2 inhibition for the treatment of chronic lymphocytic leukemiaG Del Poeta, M Postorino, L Pupo, et al.Drugs of Today (Barcelona, Spain : 1998)|December 15, 2017
Etelcalcetide: injectable calcimimetic for the treatment of secondary hyperparathyroidism in hemodialysis-dependent patientsP A Ureña Torres, J Bover, M Cohen-SolalDrugs of Today (Barcelona, Spain : 1998)|December 15, 2017
Modalities to enumerate circulating tumor cells in the bloodstream for cancer prognosis and to monitor the response to the therapyG RomanoDrugs of Today (Barcelona, Spain : 1998)|July 5, 2016
Sebelipase alfa: enzymatic replacement treatment for lysosomal acid lipase deficiencyD M PatonDrugs of Today (Barcelona, Spain : 1998)|July 5, 2016
Sonidegib phosphate: new approval for basal cell carcinomaR TibesDrugs of Today (Barcelona, Spain : 1998)|January 18, 2023
Cabotegravir: a novel HIV integrase inhibitor combined with rilpivirine as the first long-acting injectable program for the treatment of HIV infectionJohn D Zeuli, Christina G Rivera, Bradley L Smith, et al.Drugs of Today (Barcelona, Spain : 1998)|January 18, 2023
Tezepelumab for asthmaSanti Nolasco, Corrado Pelaia, Giulia Scioscia, et al.Drugs of Today (Barcelona, Spain : 1998)|January 18, 2023
COVID-19 vaccination in patients with multiple sclerosis receiving disease-modifying therapies: pragmatic issuesIoan-Alexandru Chirap-Mitulschi, Constantin Ghimus, Andreea Raluca Chirap-Mitulschi, et al.Drugs of Today (Barcelona, Spain : 1998)|June 1, 2021
Inclisiran in dyslipidemiaC E Kosmas, A Muñoz Estrella, A Sourlas, et al.Drugs of Today (Barcelona, Spain : 1998)|June 1, 2021
Inebilizumab in AQP4-Ab-positive neuromyelitis optica spectrum disorderN Siebert, A Duchow, F Paul, et al.Pageof 173